Source Count: 13 | Weighted Score: 33 | Source Confidence: [4/5] | Primary Tier: 1 | Last Updated: April 18, 2026
Keywords: altered states, default mode network, REBUS, psychedelics, ion channels, blood-brain barrier, sensory gating, anesthesia, hypnagogia, Carhart-Harris, Vollenweider
Category Tags: y2 ndes death consciousness
Cross-References: Y_2_09 — Sleep Paralysis Hypnagogia Liminal States · K_3_15 — Anesthesia Consciousness Mechanisms · K_3_18 — Bioelectricity Consciousness Transitions · X_3_30 — Barrier Permeability Consciousness Transitions

QUICK SUMMARY

Altered states of consciousness — produced by psychedelics, anesthetics, hypnagogic and hypnopompic transitions, near-death events, deep meditation, breathwork, and sensory deprivation — share a common functional signature: changes in the brain's normal information-gating systems. The Carhart-Harris / Friston REBUS model (Relaxed Beliefs Under Psychedelics) formalizes the now-converging evidence that classical psychedelics produce their characteristic effects by relaxing the precision-weighting of high-level priors implemented in the default mode network and frontal cortex, allowing normally-suppressed bottom-up sensory and emotional information to reach awareness. Anesthetics work through ion-channel permeability changes that gate large-scale cortical integration. Sensory deprivation removes one class of input gating. Breathwork and meditation modulate autonomic and attentional gating. This document synthesizes these convergent mechanisms under the unifying concept of barrier gating: altered states correspond to systematic changes in which information channels the brain normally suppresses, amplifies, or integrates.

1. VERIFIED CLAIMS (Tier 1 — Peer-Reviewed / Established)

1.1 Classical Psychedelics Act on 5-HT2A Serotonin Receptors

• Evidence: Franz Vollenweider (University of Zurich) and others established through PET imaging and pharmacological studies in the 1990s–2000s that the subjective effects of psilocybin, LSD, and DMT depend on activation of the serotonin 2A (5-HT2A) receptor, expressed densely on layer V cortical pyramidal neurons. Pretreatment with the 5-HT2A antagonist ketanserin abolishes the psychedelic effect of psilocybin in humans (Vollenweider et al., NeuroReport, 1998), confirming the receptor-specific mechanism. The receptor identification is now textbook neuroscience and provides the molecular entry point for the broader effects characterized below.
• Primary Source: K_3_15 — Anesthesia Consciousness Mechanisms

1.2 Psychedelics Reduce Default Mode Network Activity and Connectivity

• Evidence: Robin Carhart-Harris (then Imperial College London) and colleagues demonstrated in PNAS (2012) using fMRI that psilocybin reduces blood flow and BOLD signal in default mode network hubs — particularly the medial prefrontal cortex and posterior cingulate cortex — and decreases functional connectivity within the network. This finding has been replicated for LSD (Carhart-Harris et al., PNAS, 2016) and ayahuasca (Palhano-Fontes et al., PLoS ONE, 2015). KEY FINDING The default mode network is associated with self-referential processing, autobiographical memory, and the felt sense of unified self; its suppression during the psychedelic experience tracks the phenomenology of "ego dissolution" reported by participants.
• Primary Source: K_3_15 — Anesthesia Consciousness Mechanisms

1.3 The REBUS Model Formalizes Psychedelic Action as Relaxation of High-Level Priors

• Evidence: Robin Carhart-Harris and Karl Friston (UCL) published the REBUS model in Pharmacological Reviews (2019), formalizing psychedelic action within the predictive-processing / free-energy framework. The model proposes that 5-HT2A activation reduces the precision-weighting of high-level priors (top-down predictions) implemented in associative cortex and default mode hubs, allowing bottom-up prediction errors normally suppressed by those priors to propagate further up the cortical hierarchy. The framework predicts the phenomenology (vivid imagery, dissolution of self-other boundaries, novel insight) and several neural observations (increased entropy of brain activity, increased between-network connectivity). REBUS is now the dominant theoretical framework in psychedelic neuroscience.
• Primary Source: K_3_15 — Anesthesia Consciousness Mechanisms

1.4 General Anesthetics Disrupt Cortical Information Integration via Ion-Channel Action

• Evidence: As characterized in K_3_15 and K_3_18, general anesthetics produce loss of consciousness by acting on specific ion channels (GABA-A potentiation, NMDA inhibition, K+ leak channel activation) and consequently disrupting large-scale cortical integration measured by Perturbational Complexity Index (PCI) and similar metrics. This is the most robust, clinically replicable example of consciousness alteration via direct manipulation of neural permeability barriers — the membrane and channel state.
• Primary Source: K_3_18 — Bioelectricity Consciousness Transitions

1.5 Psychedelic Therapy Shows Clinical Efficacy in Treatment-Resistant Depression

• Evidence: Multiple Phase 2 randomized clinical trials have reported significant antidepressant effects from psilocybin-assisted therapy in patients with treatment-resistant major depression (e.g., Carhart-Harris et al., NEJM, 2021, comparing psilocybin to escitalopram; Davis et al., JAMA Psychiatry, 2021). Effect sizes are large (often Cohen's d > 1.0) relative to standard antidepressant treatment, and durability extends to weeks or months after a single dose. KEY FINDING The mechanism is thought to involve REBUS-style relaxation of rigid, depressogenic high-level priors, enabling reorganization of self-narrative and emotional response patterns. FDA Breakthrough Therapy designations have been granted for psilocybin (depression) and MDMA (PTSD).
• Primary Source: K_3_15 — Anesthesia Consciousness Mechanisms

2. CREDIBLE CLAIMS (Tier 2 — Academic / Debated but Supported)

2.1 Psychedelics Increase the Entropy and Repertoire of Brain States

• Evidence: Building on REBUS, Carhart-Harris has proposed the "entropic brain" framework (Frontiers in Human Neuroscience, 2014) — that psychedelic states correspond to a measurable increase in the entropy of large-scale brain dynamics, with the brain accessing a wider repertoire of functional configurations than in normal waking. Empirical support comes from increased Lempel-Ziv complexity of MEG signals (Schartner et al., Scientific Reports, 2017) and increased between-network functional connectivity. The entropy increase is consistent with the relaxation-of-priors story (constraints loosened → state space explored more freely).
• Primary Source: K_3_15 — Anesthesia Consciousness Mechanisms

2.2 Hypnagogic Transitions Show Distinctive Bioelectric Signatures

• Evidence: The hypnagogic transition between waking and sleep shows characteristic shifts: alpha rhythm decline, theta wave emergence, transient hippocampal involvement, partial thalamocortical decoupling. Phenomenologically these correspond to the well-known hypnagogic experiences — vivid imagery, false awakenings, sleep paralysis when atonia onset precedes consciousness offset, occasional auditory hallucinations. Allan Hobson characterized these transitions in detail across decades of work culminating in Dream Life: An Experimental Memoir (2011) and earlier AIM model papers. The transitions provide a natural laboratory for studying how consciousness states change when the brain's normal arousal-regulation gating shifts.
• Primary Source: Y_2_09 — Sleep Paralysis Hypnagogia Liminal States

2.3 Sensory Deprivation Produces Reproducible Altered States

• Evidence: Flotation tanks (sensory isolation chambers, popularized in the 1950s by John C. Lilly) produce consistent altered-state phenomenology including visual imagery, time distortion, and reduced anxiety, characterized in modern controlled trials (e.g., Justin Feinstein, Laureate Institute for Brain Research, PLoS ONE, 2018). The mechanism is straightforwardly understood as removal of one class of bottom-up input — the brain's predictive machinery, no longer constrained by external sensory data, generates more elaborate internal content. This is the simplest demonstration that altering input gating reliably alters consciousness state.
• Primary Source: Y_2_09 — Sleep Paralysis Hypnagogia Liminal States

2.4 Meditation Modulates Default Mode Network Activity

• Evidence: Long-term meditators show reduced default mode network activity at rest (e.g., Judson Brewer and colleagues, PNAS, 2011), with experienced practitioners able to suppress DMN activation during specific meditative states. The functional similarity to psychedelic-induced DMN suppression has been noted explicitly: meditation and psychedelics may produce phenomenologically related states (reduced self-referential processing, increased present-moment awareness) via partially overlapping neural mechanisms. Long-term meditation practice produces structural brain changes (cortical thickness, gray matter density) documented in MRI studies (e.g., Lazar et al., NeuroReport, 2005).
• Primary Source: Y_2_09 — Sleep Paralysis Hypnagogia Liminal States

2.5 Breathwork Practices Produce Altered States via Autonomic Modulation

• Evidence: Holotropic breathwork (developed by Stanislav Grof) and similar hyperventilation-based practices produce reproducible altered states characterized by emotional release, vivid imagery, and occasionally mystical experience. The proximate mechanism involves respiratory alkalosis, cerebral vasoconstriction, and altered central nervous system pH — physiological changes that in turn affect ion-channel function and large-scale cortical activity. While Grof's broader theoretical claims remain controversial, the empirical reality of altered-state induction by breathing manipulation is well-documented and has been adopted into many contemplative traditions (pranayama, tummo, etc.).
• Primary Source: Y_2_09 — Sleep Paralysis Hypnagogia Liminal States

3. SPECULATIVE CLAIMS (Tier 3 — Possible but Unverified)

3.1 Altered States Across Diverse Inductions Share a Common Functional Signature

• Evidence: Psychedelics, anesthetic dissociation (subanesthetic ketamine), deep meditation, NDE reports, and certain mystical experiences across traditions show striking phenomenological convergence — boundary dissolution, time distortion, ineffability, sense of unity, noetic certainty. William James noted this convergence in The Varieties of Religious Experience (1902); Walter Stace systematized the cross-cultural mystical-experience features in Mysticism and Philosophy (1960); modern empirical work using the Mystical Experience Questionnaire (MEQ) has confirmed reliable cross-induction phenomenological structure. [KEY FINDING — INFERENCE] The convergence has been used to argue that diverse mechanisms (5-HT2A activation, NMDA antagonism, attentional restructuring, autonomic shift, hypoxia) all access a final-common-pathway state — speculatively, a state of maximally relaxed top-down gating across multiple functional systems.
• Primary Source: Y_2_09 — Sleep Paralysis Hypnagogia Liminal States

3.2 Some NDE Phenomenology May Reflect a Shared Bioelectric End-State

• Evidence: Cardiac-arrest EEG recordings (e.g., Vicente et al., Frontiers in Aging Neuroscience, 2022) have documented transient gamma-band surges at and shortly after circulatory arrest. Researchers have proposed that NDE experiences reflect brain activity during these gamma surges — a final episode of integrated activity before bioelectric activity dissolves. This connects NDE phenomenology with the broader altered-states framework: the dying brain may transit through a state of relaxed top-down gating analogous in structure to deep psychedelic experience, accounting for the noted phenomenological similarities (life review, light, OBE-like content). This is a lively area of speculation; sample sizes are tiny and interpretation contested.
• Primary Source: Y_2_09 — Sleep Paralysis Hypnagogia Liminal States

3.3 Psychedelic-Assisted Therapy May Produce Lasting Changes Through Altered Belief Updating

• Evidence: The clinical durability of single-session psychedelic-assisted therapy effects (Tier 1.5) is striking and not well-explained by conventional pharmacological models (which predict effects scaling with drug duration). The REBUS framework offers a candidate explanation: by transiently relaxing high-level priors, the psychedelic experience creates a window in which previously rigid maladaptive beliefs about self, world, and future can be revised, with the revisions persisting after the drug clears. Carhart-Harris has framed this as "pivotal mental states" (Pharmacological Reviews, 2019). Empirical support is suggestive but not yet definitive: the precise mechanism by which a single-session experience produces months of clinical benefit remains incompletely understood.
• Primary Source: K_3_15 — Anesthesia Consciousness Mechanisms

4. DUBIOUS CLAIMS (Tier 4 — No Credible Source / Contradicted by Evidence)

4.1 The "DMT-Pineal Gland" Hypothesis (Strong Form)

• Evidence: Rick Strassman's 2001 book DMT: The Spirit Molecule speculated that endogenous DMT produced by the pineal gland might mediate dreaming, near-death experiences, and birth experiences. The pineal gland does not produce DMT in physiologically meaningful concentrations in humans (subsequent assays found at most trace amounts, far below psychoactive thresholds), and Strassman himself in later work has stepped back from the strong claims. While endogenous DMT is real and is produced in mammalian brain at low levels (Dean et al., Scientific Reports, 2019, demonstrated DMT in rodent cortex), the claim that pineal-gland DMT release produces NDEs, dreams, or mystical states in humans is not supported by current evidence. DEBUNKED in its strong popular form, while a weaker version (endogenous DMT plays some role in some altered states) remains an open empirical question.

Counter-Arguments & Criticisms

The strongest critique of the unifying "barrier gating" framework adopted here is that it lumps together mechanisms that are biophysically distinct: cell-membrane ion-channel state (anesthetics), cortical-network precision-weighting (psychedelics), thalamocortical gating (sleep transitions), autonomic state (breathwork), and sensory input gating (deprivation). Calling all of these "barrier gating" risks losing the mechanistic specificity that makes each story powerful in its own right. The defense: these are distinct mechanisms operating at distinct levels, but they share a common functional outcome — altering the normal flow of information into and within the conscious system — and that shared functional outcome is theoretically meaningful even though the substrates differ.

A second critique applies specifically to REBUS: the framework is mathematically elegant but empirically under-constrained. Almost any neural finding can be retrofit into "relaxed priors" or "increased entropy," making the model hard to falsify in its strongest form. Andreas Mathys, Bence Marosi, and others have argued for tighter quantitative tests linking specific REBUS predictions to specific neural and behavioral measurements; the field is moving in this direction.

A third caution about psychedelic clinical data: the trials are large enough to be highly suggestive but small enough that questions about blinding, expectancy effects, and patient selection remain open. The blinding problem is particularly acute — patients usually know whether they received a psychedelic or a placebo. Phase 3 trials currently underway should provide clearer signal.

IMAGES

No images assigned yet.

BIBLIOGRAPHY

1. Vollenweider, Franz X., Margreet F | 1998 | "Psilocybin Induces Schizophrenia-Like Psychosis in Humans via a Serotonin-2 Agonist Action" | NeuroReport | ∅ | 9.17::3897–3902 | I | ∅ | doi:10.1097/00001756-199812010-00024 | ∅ | ∅ | Vollenweider-Scherpenhuyzen, Andreas Bäbler, Helen Vogel, and Daniel Hell
2. Carhart-Harris, Robin L., David Erritzoe, Tim Williams, James M | 2012 | "Neural Correlates of the Psychedelic State as Determined by fMRI Studies with Psilocybin" | Proceedings of the National Academy of Sciences | ∅ | 109.6::2138–2143 | Stone, Laurence J | ∅ | doi:10.1073/pnas.1119598109 | ∅ | ∅ | Reed, Alessandro Colasanti, Robin J; Tyacke, et al
3. Carhart-Harris, Robin L.; Karl J | 2019 | "REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics" | Pharmacological Reviews | ∅ | 71.3::316–344 | Friston | ∅ | doi:10.1124/pr.118.017160 | ∅ | ∅ | ∅
4. Carhart-Harris, Robin L., Bryony Bossong, Tim Williams, Mendel Kaelen, David Erritzoe, James Rickard, Mark Bolstridge, et al | 2021 | "Trial of Psilocybin versus Escitalopram for Depression" | New England Journal of Medicine | ∅ | 384.15::1402–1411 | ∅ | ∅ | doi:10.1056/NEJMoa2032994 | ∅ | ∅ | ∅
5. Davis, Alan K., Frederick S | 2021 | "Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial" | JAMA Psychiatry | ∅ | 78.5::481–489 | Barrett, Darrick G | ∅ | doi:10.1001/jamapsychiatry.2020.3285 | ∅ | ∅ | May, Mary P; Cosimano, Nathan D; Sepeda, Matthew W; Johnson, Patrick H; Finan, and Roland R; Griffiths
6. Carhart-Harris, Robin L | 2014 | "The Entropic Brain: A Theory of Conscious States Informed by Neuroimaging Research with Psychedelic Drugs" | Frontiers in Human Neuroscience | ∅ | 8::20 | ∅ | ∅ | doi:10.3389/fnhum.2014.00020 | ∅ | ∅ | ∅
7. Schartner, Michael M., Robin L | 2017 | "Increased Spontaneous MEG Signal Diversity for Psychoactive Doses of Ketamine, LSD and Psilocybin" | Scientific Reports | ∅ | 7::46421 | Carhart-Harris, Adam B | ∅ | doi:10.1038/srep46421 | ∅ | ∅ | Barrett, Anil K; Seth, and Suresh D; Muthukumaraswamy
8. Brewer, Judson A., Patrick D | 2011 | "Meditation Experience Is Associated with Differences in Default Mode Network Activity and Connectivity" | Proceedings of the National Academy of Sciences | ∅ | 108.50::20254–20259 | Worhunsky, Jeremy R | ∅ | doi:10.1073/pnas.1112029108 | ∅ | ∅ | Gray, Yi-Yuan Tang, Jochen Weber, and Hedy Kober
9. Lazar, Sara W., Catherine E | 2005 | "Meditation Experience Is Associated with Increased Cortical Thickness" | NeuroReport | ∅ | 16.17::1893–1897 | Kerr, Rachel H | ∅ | doi:10.1097/01.wnr.0000186598.66243.19 | ∅ | ∅ | Wasserman, Jeremy R; Gray, Douglas N; Greve, Michael T; Treadway, Metta McGarvey, et al
10. Feinstein, Justin S., Sahib S | 2018 | "Examining the Short-Term Anxiolytic and Antidepressant Effect of Floatation-REST" | PLoS ONE | ∅ | 13.2:: | Khalsa, Hung-Wen Yeh, Colleen Wohlrab, W | ∅ | doi:10.1371/journal.pone.0190292 | ∅ | ∅ | Kyle Simmons, Murray B; Stein, and Martin P; Paulus. e0190292
11. Vicente, Raul, Michael Rizzuto, Can Sarica, Kazuaki Yamamoto, Mohammed Sadr, Tarun Khajuria, Mostafa Fatehi, et al | 2022 | "Enhanced Interplay of Neuronal Coherence and Coupling in the Dying Human Brain" | Frontiers in Aging Neuroscience | ∅ | 14::813531 | ∅ | ∅ | doi:10.3389/fnagi.2022.813531 | ∅ | ∅ | ∅
12. Dean, Jon G., Tiecheng Liu, Sean Huff, Ben Sheler, Steven A | 2019 | "Biosynthesis and Extracellular Concentrations of N,N-Dimethyltryptamine (DMT) in Mammalian Brain" | Scientific Reports | ∅ | 9::9333 | Barker, Rick J | ∅ | doi:10.1038/s41598-019-45812-w | ∅ | ∅ | Strassman, Michael M; Wang, and Jimo Borjigin
13. Stace, Walter T | 1960 | ∅ | Mysticism and Philosophy | ∅ | ∅ | Philadelphia: J | ∅ | ∅ | ∅ | ∅ | B; Lippincott

CROSS-REFERENCE INDEX

Generated as part of the April 18, 2026 connections audit (CONNECTIONS_AND_GAPS_AUDIT Gap H5). Last Updated: April 18, 2026